Navigation Links
AnaptysBio Adds Dr. David L. Lacey and Dr. Michael Gallatin to Therapeutic Advisory Board
Date:3/15/2012

his Ph.D. in Immunology from the University of Amsterdam and spent two years as a visiting scientist at the University of California, San Diego. 

Dr. Lydon is a co-founder of AnaptysBio and won the 2009 Lasker-DeBakey Clinical Medical Research Award along with two other scientists for the development of Gleevec® (imatinib), a molecularly-targeted treatment for chronic myeloid leukemia, which converted a fatal cancer into a manageable chronic condition.  Dr. Lydon holds a doctorate in biochemistry from University of Dundee, Scotland, and has previously served as vice president, small molecule drug discovery at Amgen, Inc.  Prior to joining Amgen, Dr. Lydon was the founder, CEO and president of Kinetix, Inc., a biotech company focused on the development of selective protein kinase inhibitors. 

About AnaptysBio
Founded in 2005, AnaptysBio, Inc. is a privately-held company focused on the generation of antibody therapeutics, and the leader in the use of somatic hypermutation (SHM) for antibody discovery and optimization. SHM is the body's natural process for generating potent antibodies.  AnaptysBio's proprietary SHM-XEL platform, which couples fully human antibody libraries with in vitro somatic hypermutation (SHM) in mammalian cells to generate high affinity lead candidates, replicates key features of the human immune system and overcomes limitations of prior antibody technologies.  By harnessing the natural mechanism of antibody maturation under controlled conditions, SHM-XEL allows for the selection of optimal antibody properties such as high affinity, functionality, cross-reactivity and epitope diversity.   AnaptysBio has established broad intellectual property around the use of SHM and is currently building a pipeline of novel therapeutic antibody product candidates. Major investors in AnaptysBio include founding investor Avalon Ventures, as well as Alloy Ventures, Frazier Health
'/>"/>

SOURCE AnaptysBio, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology news :

1. David Salt is worth his salt, says Science magazine
2. Protein folding researcher David Baker to receive Sackler Prize in Biophysics
3. David Rose to present Howe School lecture on new technologies and business models, Jan. 29
4. American Society for Microbiology honors David Masopust for research on T cell memory
5. U of As David Schindler confirms untold levels of oil sands pollution on the Athabasca
6. Leader in genetics, Dr. David L. Rimoin, receives ACMG Foundation Lifetime Achievement Award
7. UMCES fisheries biologist Dr. David Secor receives USM Regents Faculty Award for research
8. Filmmakers Joel and Ethan Coen among 2011 Dan David Prize winners
9. David and Goliath viruses shed light on the origin of jumping genes: UBC study
10. Biochemist David Deamer explores how life began in new book, First Life
11. BIDMC scientist David J. Friedman, M.D., receives award from Doris Duke Charitable Foundation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... ALBUQUERQUE, N.M. A credit-card-sized anthrax detection cartridge developed ... small business makes testing safer, easier, faster and cheaper. ... causes anthrax, is commonly found in soils all over ... illness in both humans and animals. The bacteria can ... to B. anthracis may occur through skin ...
(Date:4/17/2014)... cells in bone marrow need to produce hydrogen sulfide ... according to a new study from the Center for ... Dentistry of USC. , Professor Songtao Shi, principal investigator ... produced by the cells governs the flow of calcium ... signals that results in osteogenesis, or the creation of ...
(Date:4/17/2014)... that devastate honeybees in Europe, Asia and the United ... appear to be impacting native honeybee populations at this ... invasive pests include including Nosema microsporidia and ... to be resilient to these invasive pests, which suggests ... in Europe, Asia and the United States currently are ...
Breaking Biology News(10 mins):Pocket-sized anthrax detector aids global agriculture 2Pocket-sized anthrax detector aids global agriculture 3East African honeybees are safe from invasive pests… for now 2East African honeybees are safe from invasive pests… for now 3
... available in German . , Over 100,000 ... research, the factors that trigger the disease and influence its ... Neurobiology in Martinsried and an international research team have succeeded ... would appear that B cells play an unexpected role in ...
... in German . No progress ... medicine. The chances of cure for those affected can ... transferred from the laboratory into clinical practice. Framework conditions ... now be optimized in Germany. Last Tuesday, German Research ...
... throughout the Caribbean have been comprehensively ,flattened, over the last ... University of East Anglia (UEA). The collapse of reef ... a double whammy for fragile coastal communities in the region. ... the Caribbean was in decline, but this is the first ...
Cached Biology News:Tracking down the causes of multiple sclerosis 2Tracking down the causes of multiple sclerosis 3Tracking down the causes of multiple sclerosis 4German Research Minister Schavan: 'Rapid knowledge transfer can safe lives' 2German Research Minister Schavan: 'Rapid knowledge transfer can safe lives' 3Caribbean coral reefs flattened 2
(Date:1/15/2014)... is the device," Nobel laureate Herbert Kroemer famously ... found at the junctures where layers of different ... the interfaces between layers of metal oxides are ... favorites as spintronics, high-temperature superconductors, ferroelectrics and multiferroics. ...
(Date:1/15/2014)... 2014   Niagara Thermal Products is proud to ... Technologies LLC ("B3") as the critical thermal component supplier ... the Army Corps of Engineers.  B3 has developed the ... contaminants and destroys VOCs and other chemical pollutants, allergens ...
(Date:1/15/2014)... SAN JOSE, California , January 15, 2014 ... conjugates for cancer, today announced the appointment of Thomas C ... has over 20 years, development experience gained in the biotechnology ... "I am delighted to welcome Tom at this ...
(Date:1/15/2014)... A study has been launched to test whether ... could help to tackle the problem of obesity.  This unique ... surgery based in Stowmarket) and academics at University Campus Suffolk ... technology, which is inspired by equipment used to collect data ...
Breaking Biology Technology:A deeper look at interfaces 2Niagara Thermal Products LLC Selected as Critical Supplier for Buffalo BioBlower Air Purification Systems 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4
... Cytopia Limited (ASX: CYT) ("Cytopia") has today announced that ... an exclusive and binding Implementation Agreement ("Agreement") in which ... the issued shares and options in Cytopia. This transaction ... shareholders (and optionholders if required)(i) are expected to vote ...
... Sweden, October 5 , - A New Miniaturized ... the Price of QuanTyper(TM) Without Loss of Performance, ... , AlphaHelix (Ticker: ALPH) has in a ... demands for lower,instrument prices. This was made possible through know-how obtained ...
... 5 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY ) ... Williams, Ph.D., Chief Executive Officer of ZymoGenetics, Inc. (Nasdaq: ... pleased to welcome Doug to our board of directors ... to Oncothyreon. His extensive experience in drug development, research ...
Cached Biology Technology:Cytopia Merger with Toronto-based YM BioSciences Inc. 2Cytopia Merger with Toronto-based YM BioSciences Inc. 3Cytopia Merger with Toronto-based YM BioSciences Inc. 4Cytopia Merger with Toronto-based YM BioSciences Inc. 5Cytopia Merger with Toronto-based YM BioSciences Inc. 6Cytopia Merger with Toronto-based YM BioSciences Inc. 7AlphaHelix Presents AmpXpress(TM) at the BIOTECHNICA Show 2Oncothyreon announces appointment of Douglas E. Williams, Ph.D., to board of directors 2